Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Flat-coated retrievers set to benefit from new cancer research
Flat-coated retrievers are particularly susceptible to histiocytic sarcoma.

Simple blood test could allow for the early detection of the disease

One of the UK’s native gun dogs, the flat-coated retriever, is set to benefit from new research into a rare but aggressive form of cancer.


Research shows more than 50 per cent of flat-coated retrievers die of cancer and the breed is particularly susceptible to histiocytic sarcoma (HS) - a type of cancer found in multiple locations across the body. The outlook for the disease is extremely poor and, in most cases, terminal. 

Now scientists at the Animal Health Trust (AHT) and the University of Cambridge are set to carry out new research into the creation of a blood test for the early detection of HS in flat-coated retrievers. An early diagnosis would improve the chances of successful treatment and extend survival time.


Dr Anna Hollis, a cancer researcher at the AHT, said: “I have flat-coated retrievers and have lost one of them to histiocytic sarcoma - it is absolutely devastating. This research could make a significant difference, and that is a huge personal motivation for me."

In the study, researchers plan to confirm if there is a specific microRNA ‘signature’ that is unique to HS amongst tumours and tissue samples from flat-coated retrievers. MicroRNAs are often found in tumours and vary between different types of cancer.

If such a signature is identified, the project will investigate if measuring the levels of these microRNAs within a flat-coated retriever tissue sample can be used to identify a histiocytic sarcoma.

Should the team identify a microRNA ‘signature’ in histiocytic tumours, they will then seek additional funding to see if the same signature can be identified in the blood of affected dogs. If they find a microRNA signature, this could potentially be identified by a single blood test.


This would mean that a blood sample from a flat-coated retriever that was lame could be tested for the presence of HS-associated microRNAs - allowing for the disease to be detected at an earlier stage.

Dr Hollis continued: “Often lame dogs are rested and given pain relief before imaging is sought. Delayed diagnosis is a potential problem with histiocytic sarcoma given its aggressive nature and ability to spread rapidly to other locations within the body. 


"If we could identify affected dogs at an earlier stage, this may allow more successful treatment of the disease.”

Become a member or log in to add this story to your CPD history

VMD responds to Solensia injection concerns

News Story 1
 The VMD has added anaphylaxis to the SPC of Solensia 7 mg/ml Solution for Injection for Cats.

It says that this is a rare side effect, with such adverse events affecting fewer than three animals for every 1000 doses of Solensia sold.

Solensia is used to alleviate osteoarthritis pain in cats. It contains the active ingredient frunevetmab.

Anaphylaxis joins effects such as alopecia, dermatitis, pruritus on the list of adverse effects.

The VMD says that is constantly reviewing adverse event data for all medicines. 

Click here for more...
News Shorts
Applications open for RCVS Fellowship

The Royal College of Veterinary Surgeons (RCVS) has opened applications for veterinary surgeons to join the RCVS Fellowship.

The RCVS Fellowship is a learned society which works to advance veterinary standards and promote scientific excellence.

Veterinary surgeons can enter the RCVS Fellowship through three routes, each with different criteria. This enables people with a range of expertise and experience to join the society.

The routes are: Meritorious Contributions to Clinical Practice, Meritorious Contributions to Knowledge and Meritorious Contributions to the Profession.

Applicants must share a summary of their contributions to the profession, including examples of significant works produced throughout their career. The application will then be assessed by a panel of judges against a set of criteria.

Veterinary surgeons have until 4pm on Friday, 14 March to submit applications. More information, including requirements and guidance can be found here.